We are live on
!
Find out more
Wealthfront Advisers Portfolio holdings
AUM
$52B
Turnover
7.12%
1-Year Est. Return
24.53%
This Fund
S&P 500
This Quarter
Est. Return
-6.81%
1 Year Est. Return
+24.53%
3 Year Est. Return
+63.26%
5 Year Est. Return
+56.07%
10 Year Est. Return
–
AUM
$18.8B
AUM Growth
-$1.09B
(-5.5%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
69.6%
Holding
796
New
33
Increased
414
Reduced
312
Closed
37
Avg Time Held
2.4
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$270M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$218M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$176M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$164M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$65.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$249M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$210M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$69M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$55.4M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$44.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.79% |
| 2 | Technology | 3.22% |
| 3 | Healthcare | 2.29% |
| 4 | Financials | 1.89% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Nuveen ESG International Developed Markets Equity ETF
NUDM
$872M
| $20.7M | 0.11% |
925,834
+122,145
| +15% | +$3.05M |
2021 Q3
4 quarters
|
|
52
Pfizer
PFE
$168B
| $20.3M | 0.11% |
464,088
-145,890
| -24% | -$7.09M |
2018 Q4
15 quarters
|
|
53
Merck
MRK
$358B
| $20.3M | 0.11% |
235,530
-6,095
| -3% | -$544K |
2018 Q4
15 quarters
|
|
54
Visa
V
$750B
| $18.4M | 0.1% |
103,576
-22,996
| -18% | -$4.68M |
2018 Q4
15 quarters
|
|
55
Mastercard
MA
$540B
| $18.3M | 0.1% |
64,462
+1,078
| +2% | +$357K |
2018 Q4
15 quarters
|
|
56
McDonald's
MCD
$172B
| $18.3M | 0.1% |
79,379
+3,469
| +5% | +$887K |
2018 Q4
15 quarters
|
|
57
Walmart Inc
WMT
$935B
| $18.2M | 0.1% |
420,006
+14,124
| +3% | +$619K |
2018 Q4
15 quarters
|
|
58
Thermo Fisher Scientific
TMO
$258B
| $18.1M | 0.1% |
35,723
+1,522
| +4% | +$852K |
2018 Q4
15 quarters
|
|
59
Bank of America
BAC
$362B
| $17.6M | 0.09% |
581,573
+15,367
| +3% | +$514K |
2018 Q4
15 quarters
|
|
60
Meta Platforms (Facebook)
META
$1.88T
| $17.5M | 0.09% |
128,771
-5,192
| -4% | -$842K |
2018 Q4
15 quarters
|
|
61
Bristol-Myers Squibb
BMY
$124B
| $17.2M | 0.09% |
242,317
+5,276
| +2% | +$383K |
2018 Q4
15 quarters
|
|
62
Texas Instruments
TXN
$255B
| $17.1M | 0.09% |
110,613
+39,375
| +55% | +$6.6M |
2018 Q4
15 quarters
|
|
63
Accenture
ACN
$138B
| $17M | 0.09% |
65,970
-2,069
| -3% | -$598K |
2018 Q4
15 quarters
|
|
64
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.2B
| $17M | 0.09% |
224,168
-3,768
| -2% | -$302K |
2018 Q4
15 quarters
|
|
65
Vanguard Intermediate-Term Bond ETF
BIV
$28.4B
| $16.3M | 0.09% |
221,783
+6,248
| +3% | +$483K |
2018 Q4
15 quarters
|
|
66
Abbott
ABT
$181B
| $16.1M | 0.09% |
166,653
+31,826
| +24% | +$3.39M |
2018 Q4
15 quarters
|
|
67
Lowe's Companies
LOW
$110B
| $15.5M | 0.08% |
82,561
+15,395
| +23% | +$3M |
2018 Q4
15 quarters
|
|
68
Coca-Cola
KO
$396B
| $15.4M | 0.08% |
275,325
-10,116
| -4% | -$629K |
2018 Q4
15 quarters
|
|
69
ConocoPhillips
COP
$170B
| $14.7M | 0.08% |
143,165
-231
| -0.2% | -$23K |
2018 Q4
15 quarters
|
|
70
Schwab US TIPS ETF
SCHP
$16.3B
| $14.5M | 0.08% |
558,566
-662,068
| -54% | -$18.4M |
2018 Q4
15 quarters
|
|
71
Schwab US REIT ETF
SCHH
$10.8B
| $14M | 0.07% |
747,095
+142,034
| +23% | +$3.07M |
2018 Q4
15 quarters
|
|
72
Invesco QQQ Trust
QQQ
$487B
| $13.7M | 0.07% |
51,442
+8,556
| +20% | +$2.58M |
2018 Q4
15 quarters
|
|
73
Netflix
NFLX
$302B
| $13.6M | 0.07% |
575,530
+251,880
| +78% | +$5.59M |
2018 Q4
15 quarters
|
|
74
Intuit
INTU
$88.2B
| $13.4M | 0.07% |
34,488
+6,408
| +23% | +$2.77M |
2018 Q4
15 quarters
|
|
75
Amgen
AMGN
$235B
| $12.8M | 0.07% |
56,871
+10,768
| +23% | +$2.61M |
2018 Q4
15 quarters
|
|
Similar funds
Wealthfront Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Wealthfront Advisers held 796 positions worth $18.8B, down 5.5% from $19.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Wealthfront Advisers's Q3 2022 filing shows 33 new, 414 increased, 312 reduced and 37 closed positions. Its largest new stake was Fidelity National Financial: 101,993 shares worth $3.55M. The largest sale was State Street SPDR Nuveen ICE Municipal Bond ETF, an estimated $249M.
By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 85% a quarter earlier, followed by Technology and Healthcare.
- Wealthfront Advisers's largest Q3 2022 buy was Fidelity National Financial: 101,993 shares worth $3.55M.
- Wealthfront Advisers added most to Vanguard Tax-Exempt Bond Index Fund in Q3 2022, an estimated $270M increase.
- Wealthfront Advisers's biggest Q3 2022 reduction was State Street SPDR Nuveen ICE Municipal Bond ETF, cutting an estimated $249M.
- Wealthfront Advisers fully exited Teladoc Health in Q3 2022, selling an estimated $2.7M.
- Wealthfront Advisers's ten largest holdings make up 70% of its $18.8B portfolio in Q3 2022.
- Wealthfront Advisers opened 33 new positions and closed 37 in Q3 2022.
- Wealthfront Advisers's portfolio value fell 5.5% quarter-over-quarter to $18.8B.
Based on Wealthfront Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.